Table: Stella Pharma - Q1 parent results

Stella Pharma

06/08/2021 07:20

Aug 6 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2021        Jun 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             7 mln                                223 mln    
                                                       (+8.3 pct)   
  Operating     loss 183 mln                          loss 761 mln  
  Recurring     loss 221 mln                          loss 773 mln  
  Net           loss 222 mln                          loss 777 mln  
  EPS           loss 8.44 yen                        loss 27.68 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T